Abstract
Simple SummaryA deep knowledge of the regulation of genes involved in human adipose-derived mesenchymal stem cells (hASCs) neuronal differentiation is essential to their application in neurological disorder treatment. hASCs were induced to neuronal differentiation using three differentiation protocols and modulation of specific neuronal biomarkers and epigenetic genes changes were determined. An excellent neuronal differentiation of hASCs was obtained after Neu1 media exposure accompanied by relevant epigenetic changes in six genes including Hoxa-5. Moreover, functional analysis overexpressing the Hoxa-5 gene by CRISPR/dCas9 and lentiviral systems induced neuronal differentiation in hASCs which was improved and accelerated with the use of Neu1 media. These results suggest that Hoxa-5 plays a crucial role in the differentiation process, highlighting it as a potential candidate for the development of therapeutic strategies aimed at cell therapy in diseases related to the nervous system.Human adipose-derived mesenchymal stem cells (hASCs) may be used in some nervous system pathologies, although obtaining an adequate degree of neuronal differentiation is an important barrier to their applicability. This requires a deep understanding of the expression and epigenetic changes of the most important genes involved in their differentiation. We used hASCs from human lipoaspirates to induce neuronal-like cells through three protocols (Neu1, 2, and 3), determined the degree of neuronal differentiation using specific biomarkers in culture cells and neurospheres, and analyzed epigenetic changes of genes involved in this differentiation. Furthermore, we selected the Hoxa-5 gene to determine its potential to improve neuronal differentiation. Our results showed that an excellent hASC neuronal differentiation process using Neu1 which efficiently modulated NES, CHAT, SNAP25, or SCN9A neuronal marker expression. In addition, epigenetic studies showed relevant changes in Hoxa-5, GRM4, FGFR1, RTEL1, METRN, and PAX9 genes. Functional studies of the Hoxa-5 gene using CRISPR/dCas9 and lentiviral systems showed that its overexpression induced hASCs neuronal differentiation that was accelerated with the exposure to Neu1. These results suggest that Hoxa-5 is an essential gene in hASCs neuronal differentiation and therefore, a potential candidate for the development of cell therapy strategies in neurological disorders.
Highlights
Human adipose-derived mesenchymal stem cells show clear advantages over other MSCs, such as low donor morbidity, minimal postoperative discomfort, and high cell yield
Revealed a significant increase in specific markers of neuronal stem cells (NES), young neurons (TUB-III), mature neurons (TAU, glial fibrillary acidic protein (GFAP), and tyrosine hydroxylase (TH)), and functional markers (SNAP25, choline O-acetyltransferase (CHAT), and FOXO4) in Human adipose-derived mesenchymal stem cells (hASCs) exposed to Neu1
synaptosomal-associated protein-25 (SNAP25), finding that 85 and 84% of the cells were positive for mature neuron markers (TH and TAU, respectively) and 79% were positive for the functional cell marker SNAP25
Summary
Human adipose-derived mesenchymal stem cells (hASCs) show clear advantages over other MSCs, such as low donor morbidity, minimal postoperative discomfort, and high cell yield. The hASCs can be used for differentiation into mesodermal lineage and into ectodermal and endodermal-derived tissues, including nervous tissue [2,3,4]. Despite variations in composition and duration of neuronal differentiation protocols exist, the assessment of differentiation effectiveness includes the analysis of specific neuronal markers such as Nestin (NES), Tubulin-III (TUB-III), microtubule-associated protein-2 (MAP2), enolase (ENS), and tyrosine hydroxylase (TH) [5], glial markers such as glial fibrillary acidic protein (GFAP) [6] and neuronal functional markers such as choline O-acetyltransferase (CHAT). Using a differentiation protocol containing epidermal growth factor (EGF), fibroblast growth factor (FGF), and adenosine 30 ,50 -cyclic monophosphate (cAMP), Urrutia et al [8] observed a significant increase in NES and TUB-III in differentiated MSCs from a variety of sources. Dave et al [9]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
